Jiangxi Fushine Pharmaceutical Co.Ltd(300497)
Amendment to the articles of Association
Jiangxi Fushine Pharmaceutical Co.Ltd(300497) (hereinafter referred to as “the company”) held the 27th meeting of the third board of directors on January 6, 2022, deliberated and adopted the proposal on changing the business scope and amending the articles of association. In accordance with the provisions of the company law of the people’s Republic of China, the Listing Rules of Shenzhen Stock Exchange gem (revised in 2020), the guidelines for the standardized operation of companies listed on Shenzhen Stock Exchange gem (revised in 2020), the guidelines for the governance of listed companies and other relevant laws, regulations and normative documents, and according to the actual operation of the company, The business scope of the company needs to be adjusted and the corresponding provisions of the articles of association need to be revised. The specific amendments are as follows:
Before and after revision
Article 13 business scope of the company: license Article 13 business scope of the company: drug business items: manufacturing and sales of APIs (manufacturing and sales of drugs (operating with drug production license); Production license operation), general business items: chemical production and sales: sulbactam acid, sultamicillin tosilate, manufacturing and sales of industrial raw materials (excluding dangerous chemicals); Sultamicillin base, sulbactam pivoxil, tazobactam, production and sales: sulbactam acid, tosilate, sultamicillin, meropenem, imipenem, piperacillin, AA6, sultamicillin base, sulbactam pivoxil, tazobactam, sulbactam sodium; Sales: triethylamine, diethylamine, meropenem, imipenem, piperacillin, AA6, n-butanol, dichloromethane, tetrahydrofuran, ethanol, sulbactam sodium, triethylamine, diethylamine, n-butanol, ethyl acetate, acetone, methanol, N, n-dimethyldichloromethane, tetrahydrofuran, ethanol, ethyl acetate, formamide, toluene Bromine (operate according to the approved scope of safety production permit acetone, methanol, N, N-dimethylformamide, toluene, and valid until bromine (valid until August 30, 2021 and August 30, 2024); Operate import and export business. Operate with work safety license); Operate import and export (projects subject to approval according to law and business approved by relevant departments (subject to the scope of import and export right certificate). Business activities can only be carried out after approval)***
Other provisions of the articles of association remain unchanged.
This change needs to be submitted to the general meeting of shareholders of the company for deliberation and approved by Jingdezhen market supervision and Administration Bureau. The board of directors submits to the general meeting of shareholders and authorizes the board of directors to go through relevant industrial and commercial change registration procedures. The business scope after change shall finally be subject to the approval and registration of Jingdezhen market supervision and Administration Bureau.
Jiangxi Fushine Pharmaceutical Co.Ltd(300497) January 6, 2022
